(Q38501477)

3 September 2017

title

Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers (English)

1 reference

3 September 2017

1 reference

1 reference

Sophia Hl George

1

1 reference

3 September 2017

James Greenaway

2

1 reference

3 September 2017

Anca Milea

3

1 reference

3 September 2017

Victoria Clary

4

1 reference

3 September 2017

Sanjeev Shaw

5

1 reference

3 September 2017

Monika Sharma

6

1 reference

3 September 2017

Carl Virtanen

7

1 reference

3 September 2017

Patricia A Shaw

8

1 reference

3 September 2017

publication date

8 July 2011

1 reference

3 September 2017

1 reference

3 September 2017

volume

225

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

106-117

1 reference

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

3 September 2017

cites work

1 reference

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

21 January 2018

1 reference

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

21 January 2018

1 reference

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective

21 January 2018

1 reference

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile

21 January 2018

1 reference

Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma

21 January 2018

1 reference

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

Filtering genes to improve sensitivity in oligonucleotide microarray data analysis.

21 January 2018

1 reference

PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification

21 January 2018

1 reference

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary

21 January 2018

1 reference

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

Identification of novel direct Stat3 target genes for control of growth and differentiation

21 January 2018

1 reference

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage.

21 January 2018

1 reference

Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review

21 January 2018

1 reference

GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets

21 January 2018

1 reference

Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals

21 January 2018

1 reference

C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression

21 January 2018

1 reference

CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage

21 January 2018

1 reference

Early events in the pathogenesis of epithelial ovarian cancer

21 January 2018

1 reference

Expression profiling and individualisation of treatment for ovarian cancer

21 January 2018

1 reference

Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy.

21 January 2018

1 reference

21 January 2018

1 reference

New targets and non-cytotoxics in ovarian cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2927

1 reference

3 September 2017

1 reference